Why Scientists Are Revisiting a Polarizer - Takeaways - MDSpire

Why Scientists Are Revisiting a Polarizer

The nation’s top cancer institute takes a closer look at a disputed drug.

  • By

  • Rachana Pradhan

  • February 10, 2026

  • 8 min

Share

  • 1

    The National Cancer Institute is studying ivermectin as a potential cancer treatment despite no new evidence prompting this research.

  • 2

    Ivermectin's popularity surged during the COVID-19 pandemic, fueled by fringe medical groups promoting it as a miracle cure.

  • 3

    Career scientists at the NCI express alarm over the decision to study ivermectin, citing concerns about diverting funds from promising research.

  • 4

    Previous research suggests ivermectin may have anticancer effects, but there is no evidence of its safety or efficacy in treating cancer in humans.

  • 5

    Patients are increasingly influenced by social media claims about ivermectin, leading some to delay effective cancer treatments.

Original Source(s)

Why Scientists Are Revisiting a Polarizer

  • by Rachana Pradhan

  • February 10, 2026

Related Content

FDA Grants Traditional Approval to Iptacopan in Primary IgAN

Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.

FDA Expands Bladder Cancer Regimen

KEYNOTE-B15/EV-304 demonstrated statistically significant improvements in event-free and overall survival with perioperative pembrolizumab plus enfortumab vedotin-ejfv compared with neoadjuvant gemcitabine plus cisplatin.

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.